Citation Impact
Citing Papers
Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach
2016
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
2010 StandoutScience
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout
Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer
2013
The CCR5 and CXCR4 Coreceptors—Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection
2004
Head and neck squamous cell carcinoma
2020 Standout
Anti-HIV Activity and Resistance Profile of the CXC Chemokine Receptor 4 Antagonist POL3026
2008
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression
2010
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
The FGF family: biology, pathophysiology and therapy
2009 Standout
Tumor metastasis and the lymphatic vasculature
2009
Influence of the Fibroblast Growth Factor Receptor 4 Expression and the G388R Functional Polymorphism on Cushing’s Disease Outcome
2010
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
Cushing's syndrome
2015 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
The tamoxifen dilemma
1999
Differential Extracellular Signal‐Regulated Kinases 1 and 2 Activation by the Angiotensin Type 1 Receptor Supports Distinct Phenotypes of Cardiac Myocytes
2007
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
The role of Bcl-2 family members in tumorigenesis
2003
The molecular biology of head and neck cancer
2010 Standout
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
2016 StandoutNobel
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Fibroblast growth factor signalling: from development to cancer
2010 Standout
HIV-1 Coreceptors and Their Inhibitors
2007
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
2008
Toremifene: An evaluation of its safety profile
2005
Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks
2006 StandoutNobel
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
2000
The Fibroblast Growth Factor signaling pathway
2015 Standout
Excision of tamoxifen-DNA adducts by the human nucleotide excision repair system.
2000 StandoutNobel
Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
2012
Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review
2008
Cancer Genome Landscapes
2013 StandoutScience
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.
2001
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
2015 Standout
Works of Jun‐ichi Tanuma being referenced
Biological and Genetic Characterization of a Human Immunodeficiency Virus Strain Resistant to CXCR4 Antagonist T134
2001
Random Nuclear p53 Overexpression Pattern In Tamoxifen-Mediated Endometrial Carcinoma
1998
Immunohistological evaluation of Ki‐67, p63, CK19 and p53 expression in oral epithelial dysplasias
2006
Expressions of junB and c‐fos are enhanced in 4‐nitroquinoline 1‐oxide‐induced rat tongue cancers
2003
Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma
2007
Evaluation of apoptosis in human endometrial adenocarcinoma: comparison of nick end labeling and Le(y) antigen immunostaining method.
1996
FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
2010
Inverse correlation between bcl-2 expression and cell growth fraction in human endometrial adenocarcinoma tissue.
1998
FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer
2005